OSRH
Price
$1.41
Change
+$0.06 (+4.44%)
Updated
May 2 closing price
Capitalization
27.18M
VERA
Price
$25.31
Change
+$1.56 (+6.57%)
Updated
May 2 closing price
Capitalization
1.61B
3 days until earnings call
Ad is loading...

OSRH vs VERA

Header iconOSRH vs VERA Comparison
Open Charts OSRH vs VERABanner chart's image
OSR Holdings
Price$1.41
Change+$0.06 (+4.44%)
Volume$121.06K
Capitalization27.18M
Vera Therapeutics
Price$25.31
Change+$1.56 (+6.57%)
Volume$1.63M
Capitalization1.61B
OSRH vs VERA Comparison Chart
Loading...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OSRH vs. VERA commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OSRH is a Buy and VERA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 05, 2025
Stock price -- (OSRH: $1.41 vs. VERA: $25.31)
Brand notoriety: OSRH and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OSRH: 3% vs. VERA: 174%
Market capitalization -- OSRH: $27.18M vs. VERA: $1.61B
OSRH [@Biotechnology] is valued at $27.18M. VERA’s [@Biotechnology] market capitalization is $1.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OSRH’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • OSRH’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than OSRH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERA’s TA Score shows that 5 TA indicator(s) are bullish.

  • VERA’s TA Score: 5 bullish, 4 bearish.

Price Growth

OSRH (@Biotechnology) experienced а +2.17% price change this week, while VERA (@Biotechnology) price change was +9.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.30%. For the same industry, the average monthly price growth was +8.07%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.61B) has a higher market cap than OSRH($27.2M). VERA YTD gains are higher at: -40.151 vs. OSRH (-87.771).
OSRHVERAOSRH / VERA
Capitalization27.2M1.61B2%
EBITDAN/A-144.42M-
Gain YTD-87.771-40.151219%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A641M-
Total DebtN/A54.6M-
TECHNICAL ANALYSIS
Technical Analysis
VERA
RSI
ODDS (%)
Bullish Trend 4 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 28 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
75%
Aroon
ODDS (%)
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Ad is loading...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWPIX20.730.43
+2.12%
AB Sustainable Intl Thematic I
JANRX18.010.35
+1.98%
Janus Henderson Global Select D
SCREX36.250.51
+1.43%
Sterling Capital Rl Estt R6
TWUAX78.781.08
+1.39%
American Century Ultra® A
JNGSX11.800.14
+1.20%
Janus Henderson Global Real Estate D

OSRH and

Correlation & Price change

A.I.dvisor tells us that OSRH and MIST have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSRH and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSRH
1D Price
Change %
OSRH100%
+4.44%
MIST - OSRH
29%
Poorly correlated
-0.76%
EDSA - OSRH
23%
Poorly correlated
+0.17%
EDIT - OSRH
23%
Poorly correlated
+1.23%
VERA - OSRH
21%
Poorly correlated
+6.57%
IFRX - OSRH
20%
Poorly correlated
-6.49%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with DNLI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+6.57%
DNLI - VERA
45%
Loosely correlated
+2.37%
CRNX - VERA
44%
Loosely correlated
+1.11%
XNCR - VERA
43%
Loosely correlated
+3.68%
XENE - VERA
42%
Loosely correlated
+0.50%
ETNB - VERA
42%
Loosely correlated
+7.38%
More